Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A3 | Q9HAS3 | 7/20 | 1.00 |
| ▸ | SLC5A1 | P13866 | 6/20 | 0.66 |
| ▸ | HPGD | P15428 | 2/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | THRB | P10828 | 1/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.66 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.66 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29353844 | 1.00 | SLC28A3 (1.00) | SLC28A3SLC5A1HPGDHSD17B10KDM4E | |
| SCHEMBL29083298 | 1.00 | SLC28A3 (1.00) | SLC28A3SLC5A1HPGDHSD17B10KDM4E | |
| SCHEMBL31677394 | 0.87 | SLC28A3 (0.77) | SLC28A3SLC5A1KDM4EMAPTPOLB | |
| SCHEMBL30834914 | 0.84 | SLC28A3 (0.72) | SLC28A3SLC5A1HPGDHSD17B10KDM4E | |
| SCHEMBL31345861 | 0.83 | SLC28A3 (0.71) | SLC28A3SLC5A1HPGDHSD17B10KDM4E | |
| SCHEMBL29711455 | 0.83 | SLC28A3 (0.70) | SLC28A3SLC5A1HPGDHSD17B10KDM4E | |
| SCHEMBL29904155 | 0.82 | SLC28A3 (0.70) | SLC28A3SLC5A1HPGDHSD17B10KDM4E | |
| Lalioside SCHEMBL29350257 | 0.81 | SLC28A3 (0.69) | SLC28A3SLC5A1HPGDHSD17B10KDM4E | |
| Lalioside SCHEMBL21130709 | 0.81 | SLC28A3 (0.69) | SLC28A3SLC5A1HPGDHSD17B10KDM4E | |
| Phlorizin SCHEMBL23802544 | 0.80 | SLC5A1 (1.00) | SLC28A3SLC5A1HPGDHSD17B10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220204776-A1 | PROCESS FOR PREPARING A LAWSONIA INERMIS EXTRACT | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2022-06-30 | — | — | US | disclosed |
| WO-2020249746-A1 | PROCESS FOR PREPARING A LAWSONIA INERMIS EXTRACT | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2020-12-17 | — | — | WO | disclosed |
| WO-2019115651-A1 | EXTRACT OF THE AERIAL PARTS OF LAWSONIA INERMIS AND ITS PREPARATION METHOD | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2019-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220204776-A1 | PROCESS FOR PREPARING A LAWSONIA INERMIS EXTRACT | KRT18, LMNB1, CKMT1A; CKMT1B | SLC28A3 4875/4885SLC5A1 4816/4885HPGD 2849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.